Search Within

Taha Merghoub

Formats
  1. Meeting Abstract (186)
  2. Journal Article (166)
  3. Book Section (3)
  4. Editorial (3)
  5. Review (3)
  6. Conference Paper (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (364)
  2. Melanoma and Immunotherapeutics Service (364)
  3. Solid Tumor Oncology Division (364)
  4. GSK Faculty (272)
  5. Sloan Kettering Institute Postdocs (207)
  6. Sloan Kettering Institute Faculty (95)

More Groups

People
  1. Jedd Wolchok (230)
  2. Sadna Budhu (75)
  3. Roberta Zappasodi (55)
  4. Cailian Liu (49)
  5. Alan Houghton (45)
  6. Daniel Hirschhorn Cymerman (42)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (37)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (55)
  2. Cancer Research (44)
  3. Blood (29)
  4. Journal of Clinical Oncology (25)
  5. Journal of Investigative Dermatology (17)
  6. Journal of Immunology (12)

More Publications

Publishers
  1. American Association for Cancer Research (68)
  2. Biomed Central Ltd (55)
  3. American Society of Hematology (29)
  4. Nature Publishing Group (29)
  5. Cell Press (28)
  6. American Society of Clinical Oncology (26)

More Publishers

Results (364)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Isoform specific TGF-β inhibition in combination with radiation therapy as a novel immune therapeutic approach to cancer therapy
    Meeting Abstract

    Gupta, A.; Budhu, S.; Giese, R.; van Snick, J.; Uyttenhove, C.; Ritter, G.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Characterization of the anti-CTLA-4 antibody AGEN1884, including toxicology and pharmacology assessments in non-human primates
    Meeting Abstract

    Gombos, R.; Gonzalez, A.; Manrique, M.; Chand, D.; Savitsky, D.; Morin, B.; Breous-Nystrom, E.; Dupont, C.; Ward, R.; Mundt, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity
    Meeting Abstract

    Chand, D.; Savitsky, D.; Gonzalez, A.; Clarke, C.; Schuster, A.; Drouin, E. E.; Waight, J. D.; Mundt, C.; Ritter, G.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Investigating the kynurenine pathway as a central effector mechanism of tumor immune-suppression and its potential as therapeutic target
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Zhang, X. M.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Heat-inactivated modified vaccinia virus Ankara (MVA) as vaccine adjuvant
    Meeting Abstract

    Yang, N.; Shuman, S.; Merghoub, T.; Wolchok, J.; Deng, L.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term pancreatic cancer survivors
    Meeting Abstract

    Balachandran, V.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient
    Meeting Abstract

    Jiménez-Sánchez, A.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; Ricca, J.; Zamarin, D.; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
    Journal Article

    Luksza, M.; Riaz, N.; Makarov, V.; Balachandran, V. P.; Hellmann, M. D.; Solovyov, A.; Rizvi, N. A.; Merghoub, T.; Levine, A. J.; Chan, T. A.; more...
    Nature (2017)

    Fulltext@MSK | Save